Home > Drug Search >
  • company_query: Apexigen
  •   > 
Drug Filter
Category:
chemistry (11) biology (35)
Status:
Approved (5) NDA Filing (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (17) Phase Ⅰ (15) IND Filing (3)
Clinical Stage:
Pending (3) Active (35) Discontinued (3)
Bio-Type:
Coagulation factor (2) CAR T cell therapy (1) Vaccine (10) Blood extraction (1) Microbial extract (2) Recombinant polypeptide (1) Recombinant cytokines (3) Whole antibody (8) Fab fragment (1) Fusion protein (3)
Indication:
Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Diabetic macular edema (1) Endometriosis (1) Transplant rejection (1) Epidermolysis bullosa (1) Follicular lymphoma (1) Wet age-related macular degeneration (1) Heart failure (1) Hypertension (1) Blepharospasm (1) Glabellar line (2) Inflammatory bowel disease (1) Influenza virus infection (7) Leukemia (1) Lymphoma (1) Graves ophthalmopathy (1) Mantle cell lymphoma (MCL) (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Obesity (1) Ovarian cancer (1) Post-polycythemia vera (1) Prostate cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Type 2 diabetes (3) Colorectal cancer (1) Chronic heart failure (1) Neuroblastoma (1) Pain (1) Cervical carcinoma (1) Waldenström's macroglobulinemia (WM) (1) B-cell lymphoma (1) Sickle cell disease (1) Hemophilia B (1) Neutropenia (2) Condylomata acuminata (1) Contraception (1) Hypertrophic cardiomyopathy (1) Hematological cancer (1) Cardiomyopathy (1) Respiratory syncytial virus infection (1) Diffuse large B cell lymphoma (1) Ebola virus disease (EVD) (1) Acquired thrombotic thrombocytopenic purpura (1) Human papillomavirus infections (HPV) (2) Blood coagulation disorders (1) Hemophilia (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top